Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azeliragon phase 3 trial in mild Alzheimer's disease
2016-002005-19Phase 3Unknown
- Sponsor
- vTv Therapeutics
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Azeliragon with Placebo (2 arms). Primary endpoints: ADAS-cog and CDR-sb. Status: unknown.
02
Drugs
azeliragon
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2016-002005-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002005-19.